TrialPath
High blood pressure · Boston

High blood pressure clinical trials in Boston

20 recruiting hypertension studies within range of Boston. Click any trial for full eligibility criteria and contact info.

A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults

Recruiting

Phase 1b/2 Study of HS235 Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of the Activin Signaling Inhibitor HS235 Added to Background Treatment in Adults with Pulmonary Arterial Hypertension (PAH)

PhasePhase 1 / Phase 2
TypeInterventional
Age18 Years
WhereTampa, Florida, United States + 6 more
Sponsor35Pharma Inc., a GSK company
▾Tap for details
Apply

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

NCT04555161 · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Right Heart Dysfunction
Recruiting

This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right heart dysfunction.

PhaseNA
TypeInterventional
Age18 Years
WhereLa Jolla, California, United States + 11 more
SponsorAria CV, Inc
▾Tap for details
Apply

BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement

NCT07091851 · Stroke, Hypertension, Home Blood Pressure Monitoring
Recruiting

The investigators want to improve care for people who have had a stroke. High blood pressure is the leading cause for having a second stroke and can lead to poor brain health. The goal of this study is to compare two new ways of lowering blood pressure. The first way is to help people check their blood pressure at home. The second way is to bring people together and learn about blood pressure in a group setting. The study team thinks that using both methods together will make it easier to lower blood pressure after a stroke. The study team needs this study to test these two methods together in people who have had a stroke. The investigators believe this is an important study because having high blood pressure makes having another stroke very likely. Therefore, the investigators want to lower blood pressure in people with strokes to keep their brains as healthy as possible and to help with stroke recovery.

PhaseNA
TypeInterventional
Age35 Years
WhereBoston, Massachusetts, United States
SponsorMassachusetts General Hospital
▾Tap for details
Apply

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

NCT02249923 · Pulmonary Vascular Disease, Pulmonary Arterial Hypertension
Recruiting

Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.

Phase—
TypeObservational
Age1 Day – 21 Years
WherePalo Alto, California, United States + 13 more
SponsorNew York Medical College
▾Tap for details
Apply

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

NCT05213676 · Congenital Diaphragmatic Hernia
Recruiting

The purpose of this study is to determine if de-implementation of inhaled nitric oxide (iNO) in the post-natal resuscitation/stabilization phase affects the composite outcome of extracorporeal life support (ECLS) use and/or mortality, as well as ECLS use, mortality, and/or oxygenation in congenital diaphragmatic hernia (CDH) newborns and to establish the cost-effectiveness of de-implementing iNO as a therapy in the postnatal resuscitation/stabilization phase of CDH management, which will be assessed as the incremental health system costs (savings) per prevented ECLS use and/or death.

PhasePhase 4
TypeInterventional
Age0 Months – 1 Month
WhereBirmingham, Alabama, United States + 18 more
SponsorThe University of Texas Health Science Center, Houston
▾Tap for details
Apply

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

Recruiting

This study is researching an experimental drug called REGN13335. The study is focused on participants with Pulmonary Arterial Hypertension (PAH). The aim of the study is to see how safe and effective REGN13335 is in participants with PAH who are taking other PAH medicines. The study is looking at several other research questions, including: * What side effects may happen from taking REGN13335 * How much REGN13335 is in the blood at different times * Whether the body makes antibodies against REGN13335 (which could make REGN13335 less effective or could lead to side effects)

PhasePhase 2
TypeInterventional
Age18 Years
WhereAurora, Colorado, United States + 32 more
SponsorRegeneron Pharmaceuticals
▾Tap for details
Apply

A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases

NCT07780890 · Fuchs Endothelial Corneal Dysfunction, Open Angle Glaucoma (OAG), Dry Eye Disease (DED)
Recruiting

The overall goal of this study is to develop Brillouin microscope as a novel tool for measuring biomechanical and hydration properties of human tissues in vivo.

Phase—
TypeObservational
Age20 Years – 79 Years
WhereBoston, Massachusetts, United States
SponsorMassachusetts General Hospital
▾Tap for details
Apply

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Recruiting

International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure

PhasePhase 3
TypeInterventional
Age18 Years
WhereFairhope, Alabama, United States + 770 more
SponsorAstraZeneca
▾Tap for details
Apply

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

NCT07333183 · Pulmonary Hypertension, Interstitial Lung Disease (ILD), Lung Diseases
Recruiting

This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD) on a background inhaled treprostinil.

PhasePhase 2
TypeInterventional
Age18 Years – 85 Years
WhereSanta Barbara, California, United States + 12 more
SponsorPulmovant, Inc.
▾Tap for details
Apply

WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control

NCT07523269 · Hypertension (HTN)
Recruiting

The WEARABLE-BP study will evaluate the clinical value of obtaining continual measurements using the Aktiia G1 Optical Blood Pressure Monitoring (OBPM) device in hypertensive patients, compared to using a traditional upper arm cuff for home BP monitoring. The WEARABLE-BP study aims to compare the change in unattended automated office blood pressure from baseline to 6 months between two study groups: those given an Aktiia G1 BP monitor and those given a traditional upper arm BP cuff.

PhaseNA
TypeInterventional
Age21 Years – 85 Years
WhereBoston, Massachusetts, United States
SponsorAktiia SA
▾Tap for details
Apply

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

NCT05924477 · Glaucoma
Recruiting

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris and front chamber of the eye) in efforts to minimize cell loss in the eye.

PhaseNA
TypeInterventional
Age18 Years
WhereSan Francisco, California, United States + 7 more
SponsorUniversity of Pennsylvania
▾Tap for details
Apply

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Recruiting

The investigators will study whether the drug tadalafil improves shortness of breath in 126 Veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs. The investigators will also assess whether tadalafil improves quality of life, home daily physical activity, exercise endurance, the frequency of acute flares of COPD, blood pressure in the lungs, and lung function. Veterans who enroll in the trial will be allocated by chance to either active tadalafil or an inactive identical capsule (placebo). Neither the Veteran nor the investigator will know whether the Veteran is taking tadalafil or placebo. Veterans will be followed closely in clinic or by telephone at 1, 2, 3, 4, 5, and 6 months, with attention to side effects and safety. At 1,3, and 6 months the investigators will repeat the questionnaires and testing of blood pressures in the lung and lung function. The investigators anticipate that the results of this study will determine whether tadalafil improves shortness of breath when added to usual medications for COPD.

PhasePhase 2
TypeInterventional
Age35 Years – 89 Years
WhereAurora, Colorado, United States + 4 more
SponsorVA Office of Research and Development
▾Tap for details
Apply

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

NCT06526195 · Heart Failure, Heart Diseases, Cardiovascular Diseases
Recruiting

The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

PhaseNA
TypeInterventional
Age18 Years
WherePhoenix, Arizona, United States + 69 more
SponsorAbbott Medical Devices
▾Tap for details
Apply

Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

NCT05593055 · Hypertension, Left Ventricular Hypertrophy
Recruiting

The investigators' goal is to show that in hypertensive men and women with left ventricular hypertrophy (LVH) treatment with a mineralocorticoid receptor (MR) antagonist, versus a thiazide-like diuretic, will improve coronary microvascular function and cardiac efficiency, which will associate with improvements in LV structure and function. The investigators will achieve this through a randomized, controlled, basic experimental study involving humans (BESH).

PhasePhase 4
TypeInterventional
Age18 Years – 75 Years
WhereBoston, Massachusetts, United States
SponsorBrigham and Women's Hospital
▾Tap for details
Apply

A Trial of Hydrus Microstent Versus Goniotomy

NCT06289491 · Glaucoma, Glaucoma, Open-Angle
Recruiting

The goal of this clinical trial is to evaluate the comparative efficacy and safety of Hydrus Microstent, incisional goniotomy, and excisional goniotomy when combined with cataract surgery in patients with mild and moderate open-angle glaucoma. The main questions it aims to answer are: * How do the intraocular pressure lowering effects of these three microinvasive glaucoma surgeries compare? * How do the safety profiles of these three microinvasive glaucoma surgeries compare? Participants will be randomized to one of these three microinvasive glaucoma surgeries in combination with cataract surgery.

PhaseNA
TypeInterventional
Age40 Years – 85 Years
WhereBoston, Massachusetts, United States
SponsorMassachusetts Eye and Ear Infirmary
▾Tap for details
Apply

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Recruiting

A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LAM-001 in Adults with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD).

PhasePhase 2
TypeInterventional
Age18 Years – 85 Years
WhereTucson, Arizona, United States + 3 more
SponsorIRulya Therapeutics Inc.
▾Tap for details
Apply

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

NCT06911632 · Pulmonary Hypertension, Interstitial Lung Disease (ILD)
Recruiting

MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.

PhaseNA
TypeInterventional
Age18 Years
WhereBirmingham, Alabama, United States + 40 more
SponsorTempus AI
▾Tap for details
Apply

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Recruiting

A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)

PhasePhase 1 / Phase 2
TypeInterventional
Age18 Years – 100 Years
WhereScottsdale, Arizona, United States + 86 more
SponsorNovartis Pharmaceuticals
▾Tap for details
Apply

Non-Invasive Preeclampsia Screening and Biobank

NCT06643741 · Preeclampsia (PE)
Recruiting

Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.

Phase—
TypeObservational
Age18 Years
WhereGlendale, Arizona, United States + 20 more
SponsorSequenom, Inc.
▾Tap for details
Apply

Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension

Recruiting

The goal of this study is to determine if 12 weeks of cycling exercise training at home will improve three parameters: 1) blood pressure, 2) cognition, and 3) walking ability among persons with multiple sclerosis who have high blood pressure, when compared to a group that engages in a 12-week home-based stretching program. The main questions this study aims to answer are: 1. Can home-based cycling exercise training improve blood pressure by increasing blood vessel dilation in people with multiple sclerosis? 2. Can cycling exercise training improve cognition and walking mobility in people with multiple sclerosis by improving blood pressure? The investigators will compare home-based cycling training to stretching to see if cycling training improves cognition, walking mobility, blood pressure, and fitness in people with multiple sclerosis. Participation in this study will take 13-14 weeks, with participants being randomized (like flipping a coin, a 50-50 chance of being in either group) to the home-based cycling training or the stretching group. All participants will be asked to * Visit the laboratory two times, one before the beginning of the intervention (home-base training and stretching group) and one at the end of the intervention. * During visits, participants will complete tests related to cognition, walking mobility, blood pressure and fitness.

PhaseNA
TypeInterventional
Age18 Years
WhereBoston, Massachusetts, United States
SponsorUniversity of Massachusetts, Boston
▾Tap for details
Apply